| Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells Z Li, S Bao, Q Wu, H Wang, C Eyler, S Sathornsumetee, Q Shi, Y Cao, ... Cancer cell 15 (6), 501-513, 2009 | 1528 | 2009 |
| Targeting cancer stem cells through L1CAM suppresses glioma growth S Bao, Q Wu, Z Li, S Sathornsumetee, H Wang, RE McLendon, ... Cancer research 68 (15), 6043-6048, 2008 | 546 | 2008 |
| c-Myc is required for maintenance of glioma cancer stem cells J Wang, H Wang, Z Li, Q Wu, JD Lathia, RE McLendon, AB Hjelmeland, ... PloS one 3 (11), e3769, 2008 | 480 | 2008 |
| Targeting interleukin 6 signaling suppresses glioma stem cell survival and tumor growth H Wang, JD Lathia, Q Wu, J Wang, Z Li, JM Heddleston, CE Eyler, ... Stem cells 27 (10), 2393-2404, 2009 | 406 | 2009 |
| Regulation of the pluripotency marker Rex-1 by Nanog and Sox2 W Shi, H Wang, G Pan, Y Geng, Y Guo, D Pei Journal of biological chemistry 281 (33), 23319-23325, 2006 | 266 | 2006 |
| Turning cancer stem cells inside out: an exploration of glioma stem cell signaling pathways Z Li, H Wang, CE Eyler, AB Hjelmeland, JN Rich Journal of Biological Chemistry 284 (25), 16705-16709, 2009 | 127 | 2009 |
| MiR-215 is induced post-transcriptionally via HIF-Drosha complex and mediates glioma-initiating cell adaptation to hypoxia by targeting KDM1B J Hu, T Sun, H Wang, Z Chen, S Wang, L Yuan, T Liu, HR Li, P Wang, ... Cancer cell 29 (1), 49-60, 2016 | 110 | 2016 |
| Erythropoietin receptor signaling through STAT3 is required for glioma stem cell maintenance Y Cao, JD Lathia, CE Eyler, Q Wu, Z Li, H Wang, RE McLendon, ... Genes & Cancer 1 (1), 50-61, 2010 | 106 | 2010 |
| Analysis of specialized DNA polymerases expression in human gliomas: association with prognostic significance H Wang, W Wu, HW Wang, S Wang, Y Chen, X Zhang, J Yang, S Zhao, ... Neuro-oncology 12 (7), 679-686, 2010 | 104 | 2010 |
| miR-33a promotes glioma-initiating cell self-renewal via PKA and NOTCH pathways H Wang, T Sun, J Hu, R Zhang, Y Rao, S Wang, R Chen, RE McLendon, ... The Journal of clinical investigation 124 (10), 4489-4502, 2014 | 94 | 2014 |
| REV3L confers chemoresistance to cisplatin in human gliomas: the potential of its RNAi for synergistic therapy H Wang, SY Zhang, S Wang, J Lu, W Wu, L Weng, D Chen, Y Zhang, Z Lu, ... Neuro-oncology 11 (6), 790-802, 2009 | 93 | 2009 |
| Tankyrase inhibitor sensitizes lung cancer cells to endothelial growth factor receptor (EGFR) inhibition via stabilizing angiomotins and inhibiting YAP signaling H Wang, B Lu, J Castillo, Y Zhang, Z Yang, G McAllister, A Lindeman, ... Journal of Biological Chemistry 291 (29), 15256-15266, 2016 | 77 | 2016 |
| MicroRNA-377 inhibited proliferation and invasion of human glioblastoma cells by directly targeting specificity protein 1 R Zhang, H Luo, S Wang, W Chen, Z Chen, HW Wang, Y Chen, J Yang, ... Neuro-oncology 16 (11), 1510-1522, 2014 | 66 | 2014 |
| Association of XPD polymorphisms with severe toxicity in non–small cell lung cancer patients in a Chinese population W Wu, W Zhang, R Qiao, D Chen, H Wang, Y Wang, S Zhang, G Gao, ... Clinical cancer research 15 (11), 3889-3895, 2009 | 64 | 2009 |
| A PK2/Bv8/PROK2 antagonist suppresses tumorigenic processes by inhibiting angiogenesis in glioma and blocking myeloid cell infiltration in pancreatic cancer VF Curtis, H Wang, P Yang, RE McLendon, X Li, QY Zhou, XF Wang PLoS One 8 (1), e54916, 2013 | 58 | 2013 |
| Chk2 down-regulation by promoter hypermethylation in human bulk gliomas H Wang, S Wang, L Shen, Y Chen, X Zhang, J Zhou, Z Wang, C Hu, ... Life sciences 86 (5-6), 185-191, 2010 | 37 | 2010 |
| A variant in the CHEK2 promoter at a methylation site relieves transcriptional repression and confers reduced risk of lung cancer S Zhang, J Lu, X Zhao, W Wu, H Wang, J Lu, Q Wu, X Chen, W Fan, ... Carcinogenesis 31 (7), 1251-1258, 2010 | 31 | 2010 |
| Identifying Critical Biological Effectors in Glioma Initiating Cells H Wang Duke University, 2012 | | 2012 |
